CHAMP
Live / Registered — Registered (as of 26 Mar 2024)
What this means for you
Registered since 26 Mar 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 26 Mar 2030: the §8 declaration of use).
Record
- Serial number
- 97086114
- Registration number
- 7340470
- Mark type
- Word mark
- Filed
- 21 Oct 2021
- Published for opposition
- 06 Dec 2022
- Registered
- 26 Mar 2024
- Next maintenance filing
- §8 declaration of use, due by 26 Mar 2030 (grace period to 26 Sept 2030)
- Attorney of record
- Ryan P. Hiler
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of cancer, immune-inflammatory diseases, and central nervous system diseases; pharmaceutical preparations for the prevention of cancer, immune-inflammatory diseases, and central nervous system diseases
Owner
- Ranok Therapeutics (Hangzhou) Co. Ltd., Hangzhou, CN
- Ranok Therapeutics (Hangzhou) Co. Ltd., Hangzhou, CN
- Ranok Therapeutics (Hangzhou) Co. Ltd., Hangzhou, CN
Prosecution history
- 26 Mar 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 26 Mar 2024 — REGISTERED-PRINCIPAL REGISTER
- 20 Feb 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Feb 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 26 Jan 2024 — USE AMENDMENT FILED
- 19 Feb 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Jan 2024 — TEAS STATEMENT OF USE RECEIVED
- 07 Jul 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Jul 2023 — SOU EXTENSION 1 GRANTED
- 05 Jul 2023 — SOU EXTENSION 1 FILED
- 05 Jul 2023 — SOU TEAS EXTENSION RECEIVED
- 31 Jan 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Dec 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Dec 2022 — PUBLISHED FOR OPPOSITION
- 16 Nov 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED